BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//thebench.bio//Events//EN
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:event-48@thebench.bio
DTSTAMP:20261011T090430Z
DTSTART:20261202T070000Z
SUMMARY:Beyond Agents in the Life Sciences\, Paris BioWeek
LOCATION:Singular Capital Partners\, 38 Rue des Jeuneurs\, Paris\, France
DESCRIPTION:A technical breakfast for people who want to know whether AI ag
 ents actually hold up in therapeutic research. Three short talks cover ben
 chmarking in silico target discovery pipelines\, active learning for antib
 ody-drug conjugate design\, and rescuing drug designs from the literature 
 for rare diseases\, followed by open discussion. Speakers include the CTOs
  of Orakl Oncology and Opsin and the CSO of TychoBio\, and registration ne
 eds host approval.\n\nhttps://luma.com/mmahps3b
URL:https://thebench.bio/events/beyond-agents-in-the-life-sciences-paris-bi
 oweek-2026
END:VEVENT
END:VCALENDAR